Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2,2'-(1,4-phenylene)bis(4,5-diphenyl-1H-imidazole) | 4051-59-6 | 98.0% | 514.62 g/mol | C36H26N4 | 10 MG
SDP

Catalog No. 5000247410
Encompass_Preferred

MSX-130 is a small-molecule antagonist of the C-X-C chemokine receptor 4 (CXCR4) used in research to inhibit CXCR4-mediated signaling and reduce cancer metastasis. It is supplied as a solid research reagent with defined storage and solubility recommendations suitable for in vitro and in vivo studies.

  • Small-molecule CXCR4 antagonist for research applications.
  • High purity (98.0%) suitable for biochemical assays.
  • Soluble in DMSO (≈2 mg/mL with warming or sonication).
  • Stable as powder when stored at recommended temperatures.
  • Available in common research package sizes for dose-response work.

Catalog No. 50-002-47410 Supplier Medchemexpress LLC Supplier No. HY10301010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MSX-130 is a small-molecule antagonist of the C-X-C chemokine receptor 4 (CXCR4) used in research to inhibit CXCR4-mediated signaling and reduce cancer metastasis. It is supplied as a solid research reagent with defined storage and solubility recommendations suitable for in vitro and in vivo studies.

  • Small-molecule CXCR4 antagonist for research applications.
  • High purity (98.0%) suitable for biochemical assays.
  • Soluble in DMSO (≈2 mg/mL with warming or sonication).
  • Stable as powder when stored at recommended temperatures.
  • Available in common research package sizes for dose-response work.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.